"CWZ is het topklinische ziekenhuis voor Nijmegen en de wijde omgeving. CWZ wil uitblinken op persoonlijke en waardevolle zorg dicht bij huis."

During the past decade, Canisius-Wilhelmina Ziekenhuis conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 9 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 6 clinical trials were completed. i.e. 9.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Canisius-Wilhelmina Ziekenhuis" #1 sponsor was "Radboud University Medical Center" with 46 trials, followed by "Eli Lilly and Company" with 8 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Maastricht University Medical Center" with 6 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 6 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Canisius-Wilhelmina Ziekenhuis" #1 collaborator was "Canisius-Wilhelmina Hospital" with 20 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 18 trials as a collaborator, "Catharina Ziekenhuis Eindhoven" with 8 trials as a collaborator, "Borstkanker Onderzoek Groep" with 6 trials as a collaborator and "Radboud University Medical Center" with 6 trials as a collaborator. Other collaborators include 216 different institutions and companies that were collaborators in the rest 164 trials.

According to Clinical.Site data, the most researched conditions in "Canisius-Wilhelmina Ziekenhuis" are "Prostate Cancer" (10 trials), "Breast Cancer" (6 trials), "Migraine" (4 trials), "Breast Neoplasms" (3 trials) and "Chronic Cluster Headache" (3 trials). Many other conditions were trialed in "Canisius-Wilhelmina Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Canisius-Wilhelmina Ziekenhuis" are "Drug" (85 trials), "Other" (40 trials), "Procedure" (19 trials), "Device" (15 trials) and "Behavioral" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Abiraterone Acetate" (3 trials), "Lasmiditan" (3 trials), "Prednisone" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Canisius-Wilhelmina Ziekenhuis" are 119 trials for "All" genders, 25 trials for "Male" genders and 18 trials for "Female" genders.

Currently, there are 63 active trials in "Canisius-Wilhelmina Ziekenhuis". 2 are not yet recruiting, 36 are recruiting, 21 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 66 completed trials in Canisius-Wilhelmina Ziekenhuis, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Canisius-Wilhelmina Ziekenhuis, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 51 trials that are defined as “Not Applicable".